Tests to Verify Treatment is Working
Tests to Verify Treatment is Working
Peace of mind
There are a number of laboratory tests you can use to find out whether or not your treatment if working effectively. Having this information can save you precious time and give you the chance to change to a different treatment if the current one is not working.
These Tests are available from:
Oncotrace
Available from R.G.C.C Group
Europe email: info@rgcc-europe-nw.com
USA and Canada: email: info@rgccusa.com
Circulating Tumour Cells are cancer cells which have broken away from the primary tumor and have entered the blood stream where they circulate and have the potential to generate metastatic disease. These cells can be isolated and identified and there is growing interest in their detection for the following purposes.
1. The early detection and diagnosis of new cancers
2 Monitoring existing cancers
3 Prognosis – providing information about the risk of recurrence of a current or old cancer
Source: R.G.C.C Group
CellSearch
Available from CellSearch. This is from the CellSearch website:
Changes in CTCs are predictive of disease progression among cancer patients receiving chemotherapy. The FDA-cleared CELLSEARCH® CTC Test aids in the monitoring of patients with metastatic breast, prostate*, or colorectal cancer.
Changes in CTCs are predictive of disease progression among cancer patients receiving chemotherapy. The FDA-cleared CELLSEARCH® CTC Test aids in the monitoring of patients with metastatic breast, prostate*, or colorectal cancer.
Serial testing for circulating tumor cells (CTCs) should be used in conjunction with other clinical methods for monitoring, such as imaging, lab tests, physical examination, and complete medical history to assess patient prognosis throughout the course of disease.
The AMAS Test
Available from: Oncolabinc
Physicians around the country are recommending and administering the AMAS test on a regular basis for patients at high risk for cancer, and for follow-up purposes on patients already diagnosed and/or treated for cancer.
Article source: Oncolabinc
Note for patients outside the U.S
In an email to cancerireland.ie, Oncolabinc said:
“We will do the AMAS test for European clients, but as stated below, it can be quite difficult. We have a partner in Germany who can run tests for those in Germany and Austria – patients can email us at info@oncolabinc.com requesting that information if they would like.”
The CA Profile Plus©
Available from: American Metabolic Laboratories (USA)
Treatment Monitoring
The Cancer Profile™© gives early warning signs, but it also can be used as a cancer marker test to monitor established, existing cancers. Retesting can demonstrate whether treatment regimens are working, and how they can be adjusted. The tests also are important to establish a benchmark prior to surgery. With a retest later, one can determine the surgery’s success in removing the tumor.
This also is borne out by research. For example, a study in the Journal of Tumor Marker Oncology (Luthgens M., et al., 1992, 7 [3]: 44) reports that men who had had their diseased prostates removed had distinctly lower levels of both PSA and HCG, compared with those patients with tumors remaining. Clearly, lower levels of these markers indicate a procedure’s effectiveness.
Source: American Metabolic Laboratories
HCG Urine Immunoassay
Available from: Navarro Medical Clinic
Currently, many cancer patients take advantage of the diagnostic accuracy of the HCG test as an indicator of the effectiveness of their specific mode of therapy. Thousands of cancer survivors have used this test over the years to keep track of their treatment(s) success and check on the status of their remission. Article source: Navarro Medical Clinic
Maintrac
Available from: maintrac and Genostics
maintrac monitors the response to cancer therapies
Cancer cells can change during the course of disease. Monitoring these cells in their number and structure is important for early tailoring therapy and for selecting the most effective drugs. By determining dynamics in the number of tumor cells, the tumor activity can be monitored.
Benefits for patients:
maintrac helps to find a customized, personalized and effective therapy.
maintrac enables control of success of the applied therapy.
- Enumeration of the circulating tumor cells provides us with information whether the cells successfully are reduced by the therapy or increase despite therapy, i.e. the treatment is not effective.
- During maintenance therapy, maintrac helps to determine whether therapy is still effective.
- The drugs which destroy most of the circulating tumor cells can be tested even before chemotherapy. Thus the most effective therapy can be determined. Even naturopathic therapies can be monitored.
Article source: maintrac (company website)
See also: Current and potential use of MAINTRAC method for cancer diagnosis and prediction of metastasis.
maintrac Representation for Asia & Europe
Dr. Martin Burow
Email:info@dmb-diagnostics.de
Skype: Martin.Burow
maintrac Representation for Australia and New Zealand
E drfluhrer@genostics.com.au
F https://www.facebook.com/Genostics
Page updated 2023